Further, the expression of CD44, both CD44s and CD44v, is associated with poor prognosis in a majority of cancers (Thapa and Wilson, 2016), since CD44 signaling leads to EMT, metastasis, and resistance to therapy. The gene discussed is CD44; the disease is cancer.